Gilead to Present New Data Across HIV and Emerging Antiviral Research at IDWeek 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Gilead Sciences (NASDAQ: GILD) | Delayed: 153.57 -2.94 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.51 | 52 Week High | $108.63 | |||
| Open | $154.73 | 52 Week Low | $71.39 | |||
| Day High | $155.42 | P/E | 84.85 | |||
| Day Low | $151.71 | EPS | $1.81 | |||
| Volume | 6,220,373 | |||||
